Plain-English translation of NCT06420505 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating how well the Vivo ISAR stent performs when used to treat blocked heart arteries in real-world clinical practice. The Vivo ISAR is a special stent — a tiny expandable tube that props open a narrowed artery — made without certain polymers (coating materials) that are used in older stents. Researchers want to collect data on how this medication works and how patients do over the course of one year.
Current stents have been used for many years, but doctors are always looking for ways to improve them and reduce complications like stent blockage or inflammation. This trial exists to confirm that this new type of stent is safe and effective in a large group of real patients with different types of heart disease.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the Vivo ISAR stent as part of your standard heart care — this is not an experimental procedure, but rather a device now used in routine practice. After your stent placement, you will be asked to return for follow-up visits and assessments over 12 months so the research team can track how you are doing, check for any complications, and collect data about how well the stent is working. You will continue taking your regular heart medications as prescribed by your doctor.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
France